Sunmax Biotechnology Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 475.52 million compared to TWD 364.76 million a year ago. Revenue was TWD 473.94 million compared to TWD 363.59 million a year ago. Net income was TWD 184.43 million compared to TWD 137.32 million a year ago. Basic earnings per share from continuing operations was TWD 3.39 compared to TWD 2.52 a year ago. Diluted earnings per share from continuing operations was TWD 3.38 compared to TWD 2.52 a year ago.
For the nine months, sales was TWD 1,292.15 million compared to TWD 1,012.26 million a year ago. Revenue was TWD 1,284.47 million compared to TWD 1,010.31 million a year ago. Net income was TWD 457.12 million compared to TWD 409.28 million a year ago. Basic earnings per share from continuing operations was TWD 8.39 compared to TWD 7.51 a year ago. Diluted earnings per share from continuing operations was TWD 8.38 compared to TWD 7.51 a year ago.